ArticleFrontiers in cardiovascular medicine2026
Reduced recurrence of atrial fibrillation after cryoballoon ablation in patients with preprocedural patent foramen ovale: a retrospective single-center observational cohort study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atrial septal anomalies such as patent foramen ovale (PFO), atrial septal aneurysm (ASA), and lipomatous hypertrophy of the interatrial septum (LHIS) are frequently identified by transoesophageal echocardiography (TEE) in patients undergoing atrial fibrillation (AF) ablation. While ASAs have been linked to arrhythmogenic potential, their influence on post-ablation outcomes, particularly after cryoballoon ablation (CBA), is poorly understood. Methods: In this retrospective single-center cohort study we enrolled all patients who underwent CBA-based pulmonary vein isolation (PVI) for paroxysmal or persistent AF between June 2015 and April 2024 at our center and had preprocedural TEE imaging. Interatrial septal morphology-including PFO, ASA, and LHIS-was assessed. The primary endpoint was AF recurrence, defined as any episode lasting >30 s beyond the 90-day blanking period. Kaplan-Meier analysis and Cox proportional hazards modeling were used for time-to-event analyses. Results: Among 657 patients (mean age 61.7 ± 9.6 years; 71.2% male), PFO was identified in 16.6%, LHIS in 5.7%, and ASA in 1.0%. Over a median follow-up of 19 months (IQR: 3-76), AF recurrence occurred in 26.8%. Kaplan-Meier analysis revealed a significantly lower recurrence rate in patients with PFO compared to those without PFO (HR: 0.62; 95% CI: 0.43-0.89; Conclusions: In this single-center cohort, the presence of PFO was independently associated with a lower risk of AF recurrence following CBA. These findings suggest a potential protective role of PFO and merit further prospective investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.